Suppr超能文献

[基于健康保险的情感障碍患者病例管理项目的成本效益]

[Cost effectiveness of a health insurance based case management programme for patients with affective disorders].

作者信息

Jacke Christian Olaf, Salize Hans-Joachim

机构信息

Zentralinstitut für Seelische Gesundheit, Medizinische Fakultät Mannheim, Universität Heidelberg, J 5, 68159, Mannheim, Deutschland,

出版信息

Neuropsychiatr. 2014;28(3):130-41. doi: 10.1007/s40211-014-0109-7. Epub 2014 Jun 11.

Abstract

OBJECTIVE

Health economic evaluation of a health insurance based case management intervention for persons with mood to severe depressive disorders from payers' perspective. Intervention intended to raise utilization rates of outpatient health services.

METHODS

Comparison of patients of one German health insurance company in two different regions/states. Cohort study consists of a control region offering treatment as usual. Patients in the experimental region were exposed to a case management programme guided by health insurance account manager who received trainings, quality circles and supervisions prior to intervention. Utilization rates of ambulatory psychiatrist and/or psychotherapist should be increased. Estimation of incremental cost effectiveness ratio (ICER) was intended.

RESULTS

Intervention yielded benefits for patients at comparable costs. A conservative estimation of the ICER was 44,16 euro. Maximum willingness to pay was 378,82 euro per year. Sensitivity analyses showed that this amount of maximum willingness to pay can be reduced to 34,34 euro per year or 2,86 euro per month due to cost degression effects.

CONCLUSIONS

The intervention gains increasing cost effectiveness by the number of included patients and case managers. Cooperation between health insurances is suggested in order to minimize intervention cost and to maximize patient benefits. Results should be confirmed by individual longitudinal data (bottom-up approach) first.

摘要

目的

从支付方角度对基于健康保险的针对中重度抑郁症患者的病例管理干预措施进行卫生经济评估。该干预旨在提高门诊医疗服务的利用率。

方法

比较一家德国健康保险公司在两个不同地区/州的患者情况。队列研究包括一个提供常规治疗的对照地区。实验地区的患者接受由健康保险客户经理指导的病例管理项目,该客户经理在干预前接受了培训、质量圈活动和监督。旨在提高门诊精神科医生和/或心理治疗师的利用率。对增量成本效益比(ICER)进行估计。

结果

干预措施在成本相当的情况下为患者带来了益处。ICER的保守估计为44.16欧元。每年的最大支付意愿为378.82欧元。敏感性分析表明,由于成本递减效应,这一最大支付意愿金额可降至每年34.34欧元或每月2.86欧元。

结论

随着纳入患者和病例管理人员数量的增加,该干预措施的成本效益不断提高。建议健康保险公司之间开展合作,以尽量降低干预成本并使患者受益最大化。结果应首先通过个体纵向数据(自下而上方法)进行确认。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验